181 related articles for article (PubMed ID: 18380393)
1. Syzygium cumini (L.) SKEELS (Myrtaceae) against diabetes--125 years of research.
Helmstädter A
Pharmazie; 2008 Feb; 63(2):91-101. PubMed ID: 18380393
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic drugs used in Europe prior to the discovery of insulin.
Helmstädter A
Pharmazie; 2007 Sep; 62(9):717-20. PubMed ID: 17944329
[TBL] [Abstract][Full Text] [Related]
3. Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences.
Ayyanar M; Subash-Babu P; Ignacimuthu S
Complement Ther Med; 2013 Jun; 21(3):232-43. PubMed ID: 23642956
[TBL] [Abstract][Full Text] [Related]
4. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
[TBL] [Abstract][Full Text] [Related]
5. Identification of alpha amylase inhibitors from Syzygium cumini Linn seeds.
Karthic K; Kirthiram KS; Sadasivam S; Thayumanavan B
Indian J Exp Biol; 2008 Sep; 46(9):677-80. PubMed ID: 18949899
[TBL] [Abstract][Full Text] [Related]
6. Alpha-glucosidase inhibitory activity of Syzygium cumini (Linn.) Skeels seed kernel in vitro and in Goto-Kakizaki (GK) rats.
Shinde J; Taldone T; Barletta M; Kunaparaju N; Hu B; Kumar S; Placido J; Zito SW
Carbohydr Res; 2008 May; 343(7):1278-81. PubMed ID: 18374320
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of folk medicines in the management of type 2 diabetes mellitus: results of a randomized controlled trial of Syzygium cumini (L.) Skeels.
Teixeira CC; Fuchs FD; Weinert LS; Esteves J
J Clin Pharm Ther; 2006 Feb; 31(1):1-5. PubMed ID: 16476114
[TBL] [Abstract][Full Text] [Related]
8. Vaccinium myrtillus as an antidiabetic medicinal plant--research through the ages.
Helmstädter A; Schuster N
Pharmazie; 2010 May; 65(5):315-21. PubMed ID: 20503920
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological potentials of Syzygium cumini: a review.
Srivastava S; Chandra D
J Sci Food Agric; 2013 Jul; 93(9):2084-93. PubMed ID: 23460190
[TBL] [Abstract][Full Text] [Related]
10. Effect of the extracts and fractions of Baccharis trimera and Syzygium cumini on glycaemia of diabetic and non-diabetic mice.
Oliveira AC; Endringer DC; Amorim LA; das Graças L Brandão M; Coelho MM
J Ethnopharmacol; 2005 Dec; 102(3):465-9. PubMed ID: 16055289
[TBL] [Abstract][Full Text] [Related]
11. Scientific validation of the antidiabetic effects of Syzygium jambolanum DC (black plum), a traditional medicinal plant of India.
Baliga MS; Fernandes S; Thilakchand KR; D'souza P; Rao S
J Altern Complement Med; 2013 Mar; 19(3):191-7. PubMed ID: 23030429
[TBL] [Abstract][Full Text] [Related]
12. Effects of ethanolic extract of Syzygium cumini (Linn) seed powder on pancreatic islets of alloxan diabetic rats.
Singh N; Gupta M
Indian J Exp Biol; 2007 Oct; 45(10):861-7. PubMed ID: 17948734
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemic effect of defatted seeds and water soluble fibre from the seeds of Syzygium cumini (Linn.) skeels in alloxan diabetic rats.
Pandey M; Khan A
Indian J Exp Biol; 2002 Oct; 40(10):1178-82. PubMed ID: 12693701
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic medicinal plants--between phytotherapy and lead structure research.
Helmstädter A
Pharm Hist; 2012; 54(4):99-108. PubMed ID: 24568000
[No Abstract] [Full Text] [Related]
15. Syzygium cumini (L.) Skeels: a review of its phytochemical constituents and traditional uses.
Ayyanar M; Subash-Babu P
Asian Pac J Trop Biomed; 2012 Mar; 2(3):240-6. PubMed ID: 23569906
[TBL] [Abstract][Full Text] [Related]
16. Efficient amelioration of carbon tetrachloride induced toxicity in isolated rat hepatocytes by Syzygium cumini Skeels extract.
Veigas JM; Shrivasthava R; Neelwarne B
Toxicol In Vitro; 2008 Sep; 22(6):1440-6. PubMed ID: 18538978
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Syzygium cumini seed extract against methylmercury-induced sistemic toxicity in neonatal rats.
Abdalla FH; Bellé LP; Bitencourt PE; De Bona KS; Zanette RA; Boligon AA; Athayde ML; Pigatto AS; Moretto MB
Biometals; 2011 Apr; 24(2):349-56. PubMed ID: 21207116
[TBL] [Abstract][Full Text] [Related]
18. In vitro glucose uptake activity of Aegles marmelos and Syzygium cumini by activation of Glut-4, PI3 kinase and PPARgamma in L6 myotubes.
Anandharajan R; Jaiganesh S; Shankernarayanan NP; Viswakarma RA; Balakrishnan A
Phytomedicine; 2006 Jun; 13(6):434-41. PubMed ID: 16716914
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of ferulic acid, an ethereal fraction of ethanolic extract of seed of Syzygium cumini against streptozotocin-induced diabetes in male rat.
Mandal S; Barik B; Mallick C; De D; Ghosh D
Methods Find Exp Clin Pharmacol; 2008 Mar; 30(2):121-8. PubMed ID: 18560627
[TBL] [Abstract][Full Text] [Related]
20. Beans and diabetes: Phaseolus vulgaris preparations as antihyperglycemic agents.
Helmstädter A
J Med Food; 2010 Apr; 13(2):251-4. PubMed ID: 20132042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
